Open Label Non-Randomized Phase II Study Exploring «Chemo-Free » Treatment Association with Idelalisib + Obinutuzumab in Patients with Relapsed/Refractory (R/R) Waldenstrom's Macroglobulinemia (MW), a Filo Trial: Results of the Intermediary Analysis of the Induction Phase

Authors
Publication date
7 December 2019
Publisher
HAL CCSD

Abstract

International audienc

    Similar works

    Full text

    thumbnail-image

    Available Versions

    HAL Descartes

    redirect
    oaioai:HAL:hal-02418223v1
    Last time updated on 23/03/2021

    HAL Clermont Université

    redirect
    oaioai:HAL:hal-02418223v1
    Last time updated on 27/12/2019

    Archive Ouverte en Sciences de l'Information et de la Communication

    redirect
    oaioai:HAL:hal-02418223v1
    Last time updated on 29/12/2019